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The influenza B virus encodes a unique protein, NB, a membrane protein whose function
in the replication cycle is not, as yet, understood. We engineered a recombinant influenza
B virus lacking NB expression, with no concomitant difference in expression or activity of viral
neuraminidase (NA) protein, an important caveat since NA is encoded on the same segment
and initiated from a start codon just 4 nt downstream of NB. Replication of the virus lacking NB
was not different to wild-type virus with full-length NB in clonal immortalized or complex primary
cell cultures. In the mouse model, virus lacking NB induced slightly lower IFN-a levels
in infected lungs, but this did not affect virus titres or weight loss. In ferrets infected
with a mixture of viruses that did or did not express NB, there was no fitness advantage
for the virus that retained NB. Moreover, virus lacking NB protein was transmitted following
respiratory droplet exposure of sentinel animals. These data suggest no role for NB
in supporting replication or transmission in vivo in this animal model. The role of NB
and the nature of selection to retain it in all natural influenza B viruses remain unclear.
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INTRODUCTION
Seasonal influenza illness results from infection of the
upper respiratory tract epithelium by influenza A or B
viruses. Influenza B viruses are generally less well studied
than influenza A viruses and do not give rise to pandemics
as they have no sustained animal reservoir (Jackson et al.,
2011). Nonetheless, influenza B viruses cause a significant
number of annual influenza cases and the divergence of
two antigenically distinct lineages of influenza B virus has
necessitated the recent inclusion of two influenza B strains
into the annual vaccine, resulting in a quadrivalent product
(Belshe, 2010; Rota et al., 1990).
Influenza A and B viruses are orthomyxoviruses; both have
two glycoproteins on the surface of the viral membrane,
haemagglutinin (HA) and neuraminidase (NA), which are
involved in viral entry, by binding sialic acid receptors, and
release of progeny viruses, by cleaving sialic acid, respectively.
TheM2protein is a third,minormembrane component of the
influenza A virus particle. M2 is an ion channel protein and
has several roles in the influenza A replication cycle, including
disassembly, assembly and scission, as well as modification of
the autophagy pathway and activation of the inflammasome
(Gannage´ et al., 2009; Hughey et al., 1995; Ichinohe et al.,
2010; Iwatsuki-Horimoto et al., 2006; McCown & Pekosz,
2005; Rossman et al., 2010). Influenza B viruses encode a
homologue known as BM2 with an ion channel similar in
function to that of influenza A M2, required for uncoating
and with a role in assembly of the influenza B virus particle
(Horvath et al., 1990; Imai et al., 2004; Pinto et al., 1992).
Influenza B viruses uniquely encode a fourth surface
glycoprotein, the NB protein (Shaw et al., 1983).
NB is encoded by segment six of the influenza B virus, the
same segment that encodes NA. The NB open reading frame
overlaps that of NA, and the two AUG start codons are separ-
ated by only four nucleotides, with the NB start codon being
closer to the 59 end of the mRNA (Shaw et al., 1983).
NB is an integral membrane protein of 100 amino acids,
found on the surface of infected cells (Brassard et al.,
1996). It has an 18 amino acid extracellular N terminus,
a 22 amino acid transmembrane domain and a 60 amino
acid cytoplasmic C terminus. There are two glycosylation
sites on the extracellular domain that acquire high
mannose sugars during post-translational processing.
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Multiple N-acetyl-lactosamine residues (Galb1R4-GlcNAc
b1R3) are added to these carbohydrates to form complex
structures, termed polylactosaminoglycans (Williams &
Lamb, 1986, 1988). The NB glycoprotein forms a tetramer
at the infected cell surface and is incorporated in the virion
during budding but only in relatively small numbers
(approximately 15–100 molecules per virion) (Betakova
et al., 1996; Brassard et al., 1996).
The function of NB is currently unknown. The similarity
of domain organization of NB and M2 proteins originally
led to suggestions that NB may act as the functional hom-
ologue for the influenza A virus M2 ion channel and data
from voltage conductance studies supported this notion
(Betakova et al., 1996; Fischer et al., 2000, 2001; Prem-
kumar et al., 2004; Sunstrom et al., 1996). However, the
discovery that BM2, a protein encoded on influenza B
virus RNA segment seven, served as the influenza B
virus ion channel discounted this. Therefore, it is likely
that NB serves an alternative function for influenza B
virus. Hatta and Kawaoka used reverse genetics to pro-
duce recombinant influenza B viruses that lacked NB,
indicating that the protein is not essential for virus viabi-
lity. Indeed, viruses lacking NB replicated as well as WT
virus in Madin Darby Canine Kidney (MDCK) cells. Con-
versely, in BALB/c mice the replication of the mutant
viruses was restricted compared to the WT (Hatta &
Kawaoka, 2003).
To engineer the mutations that abrogated NB expression,
Hatta and Kawaoka disrupted sequences around and
including the NB AUG start codon. However, given the
close proximity of the start codon of NB to that of the
essential viral protein NA, it was not clear whether the atte-
nuated phenotype observed in mice for the NB deletions
might result from an effect on NA expression (Williams
& Lamb, 1989).
We therefore wanted to pursue the investigation of the role of
the NB protein by using an NB mutant with intact NA gene
expression. To achieve that, a novel mutant virus, D5NB, was
generated. This virus had a premature stop codon after the
fifth amino acid of the NB sequence leaving the sequence
of NA and the upstream nucleotides that control NA trans-
lation levels unchanged. Using this viral mutant, we sought
to determine a role for NB in vitro or in vivo.
RESULTS
Generation of a recombinant influenza B virus
lacking expression of the NB protein
Segment six of a 12 plasmid reverse genetics system based
on B/Florida/04/2006 (Elderfield et al., 2015) was modified
to create a truncated NB protein. The D5NB virus was
engineered by the introduction of a premature stop
codon after the fifth amino acid of NB coding sequence
by site-directed mutagenesis. The NB open reading frame
was reduced to five amino acids whilst the NA amino
acids remained unchanged (Table 1). Both WT and
D5NB viruses were rescued and propagated in MDCK
cells. We confirmed the lack of NB expression in cells
infected with the D5NB mutant virus by Western blot of
lysates from infected cells using an NB specific monoclonal
antibody. This detected a heterogeneous range of NB pro-
teins in lysates of cells infected with WT virus, ranging in
size from 15 to 46 kDa as previously described (Williams
& Lamb 1988), that were lacking in similar lysates from
D5NB mutant virus-infected cells. Detection of equivalent
amounts of BM2 and NP showed that levels of other
viral proteins did not differ between the two viruses
(Fig. 1a).
The D5NB mutation did not affect virus
neuraminidase activity
To confirm that the mutations introduced in D5NB virus
did not affect NA, enzyme activity associated with the
mutant virus was measured using three different assays.
For the standard NA enzyme assay that employs a soluble
substrate, the MuNANA assay, the WT and mutant viruses
were standardized to equivalent p.f.u. and assessed over a
range of dilutions for their ability to cleave the
MuNANA reagent. There was no significant difference
between the two viruses (Fig. 1b).
In the red blood cell (RBC) elution assay, we assessed the
virus’ ability to desialylate red blood cells. The two viruses
were mixed with human RBCs at equal HA titres and incu-
bated at 4 uC for 1 h to allow agglutination. The plates were
then shifted to 37 uC for 6 h to permit NA activity and
observed at regular intervals for the reversal of
Table 1. Nucleotide sequence alterations engineered to generate an influenza B virus that lacks NB expression
The initiating methionines for the NB and NA proteins are single underlined and the mutations that lead to NB truncation are double underlined.
WT nucleotide sequence AATGAACAATGCTACCTTCAACTATA...
D5NB nucleotide sequence AATGAACAATGCTACCTAGTACTATA...
WT NB amino acid sequence M N N A T F N Y...
D5NB NB amino acid sequence M N N A T STOP
WT NA amino acid sequence M L P S T I...
D5NB NA amino acid sequence M L P S T I...
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haemagglutination, which would indicate desialylation of
RBCs by the viral NA. If virus eluted from the RBCs they
formed a pellet. This effect was more evident at high titres
of virus where more NA was present in the well. An end
point titre for elution was measured. The two viruses exhib-
ited the same degree of elution at all time points (Fig. 1c).
The mucus inhibition assay measured the ability of the viral
NA to cleave abundant sialic acids found in mucus, which
can act as decoy receptors, delaying viral infection (Blu-
menkrantz et al., 2013). Mucus was harvested from the
apical surface of well differentiated human airway epithelial
(HAE) cell cultures. Diluted mucus was mixed with 100
p.f.u. of each virus prior to inoculating MDCK cells.
During incubation at 37 uC on the MDCK cells, the viral
NA cleaved sialic acids in mucus enabling infection of the
cell monolayer. The infectivity remaining was determined
by comparing the number of plaques formed by virus in
the presence and absence of mucus. No significant differ-
ence in ability to overcome mucus inhibition was observed
between the WT and DNB virus (Fig. 1d).
Collectively, these results demonstrate that the D5NB
mutation did not affect NA activity.
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Fig. 1. Characterization of a virus lacking expression of NB. (a) Western blot to assess NB expression. WT and mutated
(D5NB) influenza/B/Florida/04/2006 viruses were used to infect MDCK cells at a high m.o.i. (3). After 24 h, the cells were
lysed, the proteins separated by SDS-page and transferred by Western blot. Membranes were immunostained with a mouse
anti-NB protein antibody (top panels) and a rabbit anti-BM2 protein antibody (bottom panels). The blot was detected using
the LI-COR system and the two panels separated for clarity. (b) MuNANA enzyme assay to assess NA activity. WT or
mutated (D5NB) influenza B/Florida/04/2006 viruses were serially diluted in MES buffer, MuNANA reagent was added, the
reaction was allowed to continue for 1 h prior to the addition of stop solution. The plate was read with UV excitation filter of
355 nm and emission filter of 460 nm. (c) RBC Elution Assay to assess NA activity. Influenza B/Florida/04/2006 WT or
mutant (D5NB) virus were serially diluted in PBS. 50 ml of 0.5 % fresh human RBCs were added and the plate was incubated
at 4 8C for 1 h before a temperature shift to 32 8C for 4 h. The plates were observed hourly for evidence of haemagglutina-
tion of RBCs until the end point at 6 h. (d) Mucus inhibition assay to assess NA activity. One hundred p.f.u. influenza
B/Florida/04/2006 WT or mutant (D5NB) virus were pre-incubated in human airway mucus or virus diluent prior to infection
on MDCK cells which after 1 h, after the inoculum was removed were overlaid with agar media to allow plaques to form. The
percentage reduction in plaques formed after the mucus incubation was calculated.
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D5NB influenza B virus displayed no growth
attenuation in a variety of cell types
In order to measure any effect of loss of NB protein on virus
replication kinetics we used human airway-derived Calu-3
cell cultures or primary HAE cell cultures, the latter contain-
ing a mixture of ciliated and non-ciliated cells types, with an
air interface at the apical surface onto which mucus is
secreted. In initial experiments each cell system was inocu-
lated by each virus type in separate wells at an equal m.o.i.
and the comparative growth was assessed at set time points
by plaque assay on MDCK cells. Both systems were highly
permissive for influenza B virus replication with peak titres
in excess of 107 p.f.u. ml21 in Calu-3 and 108 p.f.u. ml21
in HAE cultures. D5NB virus was not attenuated in either
cell system (Fig. 2a, b). Consensus whole genome sequencing
of virus generated during multi-step replication confirmed
no sequence variation between the WT and D5NB viruses,
except for the specifically introduced truncation.
Competition assays have increasingly been used to assess
small variations in fitness between two influenza viruses
not observable by traditional viral growth curves (Brookes
et al., 2011; Guarnaccia et al., 2013; Yen et al., 2014).
To establish whether lack of NB has a fitness cost for the
D5NB mutant virus compared with the WT virus, we
infected HAE cells with a mixture of 20 % WT and 80 %
D5NB virus at a final m.o.i. of 0.001. After multi-cycle repli-
cation over several days, the relative abundance of the two
genotypes in virus harvested from the apical surface was
measured using a pyrosequencing reaction. At no time
point was there a statistically significant difference in the
ratio of WT to D5NB from the ratio of genotypes in the
input inoculum; after 4 days replication the D5NB genotype
was still present at 80 % of the RNA population (Fig. 2c).
These results indicated that the NB protein did not offer a
selective advantage in vitro even in a complex cell culture
system in which deficiency in NA is readily measured
(Brookes et al., 2011).
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Fig. 2. Growth kinetics of virus lacking NB expression on human derived clonal or primary differentiated cell lines. (a) Influ-
enza B/Florida/04/2006 WT or mutant (D5NB) viruses were used to infect Calu-3 cells at a low m.o.i. (0.01). At 24 h inter-
vals the viral titre released was assessed by titration on MDCK cells by plaque assay. (b) Influenza B/Florida/04/2006 WT or
mutant (D5NB) viruses were used to infect Mucilair HAE cell cultures at a low m.o.i. (0.001). Time points were taken by the
addition of media to the apical surface and after 30 min the media was removed and the viral titre was assessed by titration
on MDCK cells by plaque assay. (c) Competition assay assessing the growth kinetics of virus lacking NB expression on
human differentiated primary cell cultures. Influenza B/Florida/04/2006 WT or mutant (D5NB) viruses were used to infect
Mucilair HAE cell cultures at an m.o.i. of 0.001 with a mixture of 20 % WT and 80 % D5NB virus. At 24, 48 and 72 h post-
infection, virus released from apical surface was collected in 200 ml of DMEM and after RNA extraction subjected to pyro-
sequencing to assess the relative percentages of the WT and truncated NB forms.
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The D5NB recombinant virus is not attenuated
in mice in vivo
C57BL/6mice were infected intranasally with 4.5|105 p.f.u.
of either WT or D5NB virus. The weight loss of the mice was
monitored daily. Viral titre, IFN-a and IL-1b in the lungs
were determined on days 2, 3 and 4 post-infection.
As shown in Fig. 3(a), the two viruses replicated well in
mouse lungs, with the D5NB displaying slightly higher
growth 3 days post-infection (P50.007) (Multiple t-test,
Holm-Sidakmethod). As a grossmeasurement of pathology,
weight loss was monitored (Fig. 3b). On all days, mice
infected with the WT virus displayed a slightly greater
weight loss but the difference between the two groups was
not significant (Multiple t-test, Holm-Sidak method).
As an indication of the innate immune response, IFN-a in
the mouse lungs was measured at days 2, 3 and 4 post-
infection. Significant production of IFN-a in the murine
lungs was only evident on day 2 after infection. There
was no difference in the interferon levels in the mice
infected with WT virus or those infected with the D5NB
virus, except a slight increase for the D5NB infected mice
on day 4 (P50.005) (Multiple t-test, Holm-Sidak
method) (Fig. 3c). Activation of the inflammasome was
assessed by measuring levels of IL-1b. Levels of pro-IL1b
and total IL-1b (pro form plus activated form) were
measured. Both sets of infected mice had higher total
IL-1b levels in their lungs than the mock infected animals
and this was significant at all days measured (Multiple
t-test, Holm-Sidak method). Total IL-1b protein levels
tended to be higher in the lungs of mice infected by
D5NB virus, but this difference was not significant.
Virus lacking NB expression replicates in ferrets
and is transmitted by the respiratory droplet route
We tested whether the loss of NB affected replication within
a single host or transmission onwards to a new host by
inoculating ferrets with a mixture of WT and D5NB viruses,
and monitoring the ratio of genotypes within and between
hosts using pyrosequencing. Four donor ferrets were inocu-
lated with a 1 : 1 ratio of a total of 104 p.f.u. WT and D5NB
virus. All four donors were robustly infected with the virus
mixture and shed infectious virus in their nasal wash over
the following 6 or 7 days. Peak viral titres were shed on
day 2 and were between 105 and 106 p.f.u. ml21 nasal
wash. Shedding followed a biphasic kinetic profile similar
to that we have previously reported for ferrets infected
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Fig. 3. Infection of mice with influenza B virus lacking NB expression. (a) Infectious titres of influenza B virus lacking NB
expression in lungs of infected C57BL/6 mice. Female C57BL/6 mice 6–8 weeks old were infected with 4.56105 p.f.u. of WT
B/Florida/04/2006 or D5NB virus or inoculated with PBS. At days 2, 3 and 4 post-infection lungs were isolated and homogen-
ized in 500 ml of PBS prior to virus titres being determined by plaque assay on MDCK cells. (b) Weight loss in influenza B
virus-infected mice. (c–e) Cytokine induction in C57BL/6 mice infected with WT orD5NB mutant influenza B virus. Interferon
alpha (c), IL-1b pro (d) and IL-1b (e) in the mice lungs were measured by ELISA of the homogenized lungs from (a).
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with influenza A viruses (Roberts et al., 2011) (Fig. 4a).
Pyrosequencing of RNA isolated from the daily nasal
washes showed that the relative proportions of the two
virus genotypes did not vary by more than 11 % from the
starting mix in any of the four directly inoculated hosts
and the direction of the small variation was sometimes to
favour wild-type genomes encoding full NB and sometimes
D5NB mutant genomes (Fig. 4b, c).
Only one of the four respiratory droplet (RD) exposed sen-
tinel animals acquired infection following exposure to the
infected donor. Pyrosequencing of the nasal washes from
this animal revealed that the virus it had acquired was
uniquely the D5NB genotype (Fig. 4b). This infected reci-
pient continued to shed D5NB virus for 4 days from day
6 to day 9 after it was first exposed. Peak titre in nasal
wash from this animal was 105 p.f.u. ml21.
DISCUSSION
The NB protein is absolutely conserved across influenza B
viruses, a finding that might indicate it is required for
effective replication or transmission. However, our ability
to rescue and propagate a recombinant influenza B virus
that lacks expression of NB supports the previous con-
clusion from Hatta et al. (Hatta & Kawaoka, 2003) that
NB is dispensable for virus replication in vitro. The
design of our mutant virus allowed us to investigate the
unique role of NB because we abrogated NB expression
with no concomitant effect on the NA function or activity.
Although the set of experiments we describe here does not
elucidate the function of NB, it does show that NB is not
required for replication or transmission of influenza B
virus in vitro or in vivo in mice or ferret models.
Previously, loss of NB was correlated with attenuation of
replication in vivo in the mouse lung and nasal turbinate
and an increase in MLD50, but it could not be excluded
that this phenotype arose from a change in NA expression.
In our study with an NB mutation that did not compro-
mise NA, there were minimal differences in viral titre
and weight loss and only slightly higher levels of IFN-a
in the mice infected with the truncated NB protein.
We looked carefully at the levels of IL-1b that result
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Fig. 4. Infection of ferrets with influenza B virus. Four ferrets (D1–D4) were inoculated with 104 p.f.u. of an equal mixture WT
and truncated NB virus. At 1 day post-infection, four naive ferrets were placed in adjacent cages as respiratory droplet (RD)
sentinels (RD1–RD4). (a) Infectious virus titres shed in nasal wash collected each day after infection or exposure established
by plaquing on MDCK cells. (b) The relative proportions of the two virus genotypes in daily nasal washes from a paired donor
ferret D4 and infected exposed ferret RD4 assessed by pyrosequencing. (c) The relative proportions of the two virus geno-
types in daily nasal washes from the remaining three donor ferrets D1, D2 and D3.
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from activation of the inflammasome response because
other small hydrophobic viral proteins have been impli-
cated in regulation of inflammasomes (Triantafilou et al.,
2013). For example, deletion of the SH protein of respirat-
ory syncytial virus, RSV, which is similar in size and
domain distribution to NB, led to increased induction of
proinflammatory cytokines including IL-1b, and deletion
of SH is an attenuation strategy for bovine and human
RSV vaccines under development (Karron et al., 2005;
Taylor et al., 2014). On the other hand, the ion channel
proteins of other viruses such as M2 of influenza A and
E protein of the coronavirus SARS, appear to stimulate
the inflammasome and their deletion leads to a decreased
IL-1b response (Ichinohe et al., 2010; Nieto-Torres et al.,
2014). In our experiments, loss of NB expression had a
marginal effect on IL-1b expression in the mouse lung.
We cannot exclude that a role for NB in modulating
inflammasome activation was masked in the mouse
model by other factors, or that the effects of NB are
mouse strain, host species or cell type specific for this
human pathogen.
Very recently, Kim et al. published the first study of trans-
mission of influenza B virus in ferrets (Kim et al., 2015).
In line with our data, they also report low transmission effi-
ciency of the B/Florida/04/2006 virus in the ferret model, in
contrast to a more efficient influenza B virus RD trans-
mission previously reported between guinea pigs (Pica
et al., 2012). The frequency of transmission events we
recorded between RD exposed ferrets was surprisingly
low, at just one of four exposed animals acquiring infec-
tion. We do not yet know if this observation will prove
common to a number of influenza B viruses or whether
transmission efficiency varies amongst different influenza
B virus strains. The influenza B virus we used replicated
well in the upper respiratory tract of ferrets and in well dif-
ferentiated cultures of ferret airway cells (Elderfield et al.,
2015). The low transmission efficiency of a seasonal influ-
enza virus suggests either that this animal model does have
limitations for the study of influenza B viruses, or that
some successful human influenza viruses are not necess-
arily transmitted primarily by this RD route. As far as the
NB protein is concerned, we found that in the single trans-
mission event we did record, the virus that transmitted was
uniquely of the genotype that lacked expression of NB.
Because we set up mixed infections and both mutant and
wild-type virus were replicating simultaneously in the
donor animals we cannot absolutely exclude that the
D5NB virus genome was not complemented by wild-type
NB protein during the transmission event. However, our
data unequivocally show that NB is not required for repli-
cation in the ferret model.
A recent paper also used a reverse genetics approach to
probe for a role for NB. Rather than creating a completely
null mutant, they chose to mutagenize the cytoplasmic tail
of the protein and in particular abrogate the post-transla-
tional modification of palmitoylation at residue 49 from
cysteine to serine (Demers et al., 2014). Surprisingly, in
view of our data and that of Hatta et al. that suggested
no role in vitro for NB, Demers et al. found that their pal-
mitoylation mutant was attenuated for replication in
MDCK cells. It may be that the continued expression of
an unnecessary and mutated membrane protein interfered
with the normal assembly of virus particles, but whether
this result verifies a role for the non-mutated NB protein
in wild-type influenza virus infections in vitro is not clear.
Bearing in mind the absolute conservation of NB in all
influenza B viruses isolated from clinical cases and even
in strains such as influenza B/Lee/40 that have been pas-
saged in eggs and cell culture for more than 75 years, it
is highly likely that this protein does serve a role for the
virus. However, using current technologies we have been
unable to measure a fitness cost in viruses engineered to
lack the protein either in vitro or in vivo.
METHODS
Cells.MDCK cell line and the Human lung adenocarcinoma derived
cell line (Calu-3) were maintained in DMEM (Gibco Life Technol-
ogies) supplemented with 10 % fetal bovine serum, non-essential
amino acids and penicillin/ streptomycin (Gibco Life Technologies) at
37 uC with 5 % CO2 and originated from the ATCC. The Human
Airway Epithelial cells (Mucilair HAE) were purchased from Epi-
thelix, and were maintained with the proprietary Mucilair medium.
Viruses. The B/Florida/04/2006 virus was rescued by reverse genetics
from plasmids containing cDNA synthesized de novo directly from the
database sequence (GenBank Accessions: CY033876, CY033877,
CYO33878, CY033879, CY0330880, CY033881, CY033882,
CY033883) (Elderfield et al., 2015); the D5NB mutant was generated
by site-directed mutagenesis of the segment six plasmid. The viruses
were cultured and titred in triplicate by plaque assay on MDCK cells.
Cell infections. For growth kinetic experiments in CALU-3 cells, the
cells were washed with PBS, virus was added at an m.o.i. of 0.001 in
DMEM. The inoculated cells were incubated for 1 h at 37 uC prior to
removal of the inoculum, washed with PBS and overlaid with DMEM
containing NEAA, P/S and 1 mg ml21 TPCK-trypsin (Worthington
Biosciences). Time points were taken at 24, 48 and 72 h post-infec-
tion. For the growth kinetics and competition assays in human airway
epithelial cultures, the apical surfaces of the HAE cell cultures were
washed by a 30 min incubation in 250 ml of DMEM. After removal of
the medium, virus was added at an m.o.i. of 0.001 (for the compe-
tition assay with a mixture of 20 % WT and 80 % DNB virus) in a
volume of 200 ml of DMEM. After 1 h, the inoculum was removed
and the cell layer washed with DMEM. The cultures were incubated at
37 uC at 5 % CO2 and at 24, 48, 72 and 96 h post-infection, virus
released from apical surface was collected in 200 ml DMEM.
Virus sequencing. Viral RNA was extracted using the Qiagen
QIAmp RNA kit. Reverse transcription was conducted using random
hexamers and Superscript III (Invitrogen). DNA amplification was
conducted using KOD polymerase (Novagen) and non-coding region
segment specific oligomers. DNA bands generated were excised from
agarose and cleaned using a Qiagen gel extraction kit. Sequencing was
conducted by the GATC sequencing service using the previously
mentioned oligomers and additional internal oligomers. The data
generated was analysed by alignment using Geneious software. All
oligomer sequences are available on request.
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Ferret infections. Animal studies were conducted as previously
described (van Doremalen et al., 2011) Female ferrets (14–16 weeks
old) were used. Body weight was measured daily. After acclimatiz-
ation the ferrets were anaesthetized with ketamine (22 mg kg21) and
xylazine (0.9 mg kg21) then inoculated intranasally with 104 p.f.u. of a
mix of the two RG variants of the B/Florida/04/2006 virus diluted in
DMEM (0.1 ml per nostril). All animals were nasal washed daily,
while conscious, by instilling 2 ml PBS into the nostrils, and the
expectorate was collected in 250 ml centrifuge tubes. Infectious virus
was titrated by plaque assay of the nasal wash on confluent MDCK
cells.
Mouse infections. Female C57BL/6 mice (6–8 weeks old), anaes-
thetized with isoflurane, were intranasally infected with 40 ml con-
taining 4.5|105 p.f.u. of WT or D5NB virus or with 40 ml of PBS.
Lungs were isolated and homogenized in 1 ml of PBS using the
Minilys homogenizer (Bertin Technologies) and the Precellys Ceramic
kit 1.4 mm (PeqLab). Virus titres in the lungs were determined by
plaque assay on MDCK cells.
ELISA. To detect the cytokines in the homogenized mouse lungs, the
VeriKine Mouse Interferon Alpha ELISA kit (Pbl Interferon Source)
was used to determine IFN-a levels, and R & D systems Quantikine
ELISA kit for IL-1b.
SDS-PAGE and Western blots. MDCK cells were inoculated with
B/Florida/04/ 2006 WT, D5NB or PBS at an m.o.i. of 3 and incubated
overnight at 37 uC. The cells were then lysed and the proteins were
separated on a 12 % SDS-PAGE gel and then transferred to a
membrane. The membrane was blocked in Odyssey blocking buffer
(LI-COR Biosciences) and then stained with a mouse anti-NB
monoclonal antibody (a kind gift from Dhan Samuel PHE Colindale
UK) and rabbit anti-BM2 (Jackson et al., 2004) and anti-NP primary
antibodies and then with an anti-mouse Dylight 680 and anti-rabbit
Dylight 800 conjugated secondary antibodies (Cell Signalling Tech-
nologies). The LI-COR detection system was used, allowing both NB
and BM2 to be detected in the same gel lane, the image has been split
to display both proteins in grayscale, an equal amount of lysate was
loaded onto two additional lanes and stained with anti-NP.
Pyroseqeuncing. Viral RNA was extracted from the HAE or ferret
nasal wash using the Qiagen QIAmp RNA kit. A 50-cycle PCR was
performed using the following primers: 59 GCCAAAAATGAACAA-
TGCTACCT and 39 CTGATGTGAGAAATAGGGTTAACG. The
amplified product was mixed with Sepharose beads at 1400 r.p.m. for
10 min. The beads were sequentially washed in 70 % ethanol, 0.2M
NaOH and wash buffer and transferred to a plate containing the
primer: AAAATGAACAATGCTACCT for sequencing on the Qiagen
PyroMark Q96 ID pyrosequencer.
MuNANA assay. MuNANA substrate (29-(4-Methylumbelliferyl)-a-
D-N-acetylneuraminic acid, sodium salt hydrate) (Sigma-Aldrich)
was diluted to 100 mM in MES buffer and added to a black 96-well
plate (Matrix Microplates, Thermo Scientific) containing equal p.f.u.
(4|106 in 50 ml) of WT and D5NB B/Florida/04/2006 serially diluted
twofold in MES buffer. The reactions were shaken for 60 min at 37 uC
prior to the addition of a glycine/ethanol stop solution. The plate was
then read using FLUOstar OPTIMA (BMG Labtech) with a UV ex-
citation filter set at 355 nm and emission filter at 460 nm. This was
conducted in triplicate with two different stocks of each virus.
Mucus inhibition assay. Mucus was collected from the apical sur-
face of HAE cells by incubating with equilibrated DMEM for 30 min
at 37 uC. 100 p.f.u. of WT or D5NB virus were mixed with either
1 : 70 diluted mucus or virus diluent (PBS+0.35 % BSA), these
mixtures were used to infect confluent MDCK cells (in triplicate).
At 1 h post-infection, the cells were washed with PBS and overlaid
with plaque overlay media. After 72 h, the cells were fixed and stained
with crystal violet and the plaques counted. The infectivity remaining
was calculated as the percentage of virus in mucus over the virus in
diluent alone.
RBC elution assay. 16 HA units of the B/Florida/04/2006 WT or
D5NB virus were serially diluted twofold in PBS in triplicate in a 96-
well plate. 50 ml of 0.5 % fresh human RBCs were added and the plate
was incubated at 4 uC for 1 h before a temperature shift to 37 uC for
4 h, the elutions were read hourly until the end point at 6 h.
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